Soo‐Zin Kim

Bendamustine is effective in relapsed or refractory aggressive non-Hodgkin's lymphoma.

D. Hoelzer, G. Seipelt, P. Mitrou, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin's lymphoma.

M. Hansmann, S. Al-Batran, M. Welslau, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD4+CD56+ Neoplasia: Clinical and Biological Features with Emphasis on Cytotoxic Drug-induced Apoptosis and Expression of Sialyl Lewis X

W. Sterry, T. Zollner, D. Hoelzer, 2003, Leukemia & lymphoma.

Identification of HERC5 and its potential role in NSCLC progression

M. Esteller, A. Risch, M. Westphal, 2015, International journal of cancer.

Expression of ZAP-70 Protein Correlates with Disease Stage in Chronic Lymphocytic Leukemia and is Associated with, but not Generally Restricted to, Non-mutated Ig VH Status

L. Harder, S. Boehrer, D. Hoelzer, 2004, Leukemia & lymphoma.

In bcr-abl-positive myeloid cells resistant to conventional chemotherapeutic agents, expression of Par-4 increases sensitivity to imatinib (STI571) and histone deacetylase-inhibitors.

Daniel Nowak, P. Atadja, D. Nowak, 2004, Biochemical pharmacology.

Daxx overexpression in T-lymphoblastic Jurkat cells enhances caspase-dependent death receptor- and drug-induced apoptosis in distinct ways.

D. Nowak, S. Boehrer, D. Hoelzer, 2005, Cellular signalling.

A Phase II Immunochemotherapy Study with Alemtuzumab, Fludarabine, Cyclophosphamide, and Doxorubicin (Campath-FCD) in Peripheral T-Cell Lymphomas.

M. Dreyling, M. Subklewe, G. Hess, 2006 .

In vivo drug-response in patients with leukemic non-Hodgkin's lymphomas is associated with in vitro chemosensitivity and gene expression profiling.

D. Nowak, W. Hofmann, S. Boehrer, 2006, Pharmacological research.

Identification of HERC5 and its potential role in NSCLC progression

M. Esteller, A. Risch, M. Westphal, 2015, International journal of cancer.

Expression of Daxx sensitizes Jurkat T-cells to the apoptosis-inducing effect of chemotherapeutic agents.

D. Nowak, S. Boehrer, D. Hoelzer, 2005, Pharmacological research.